Zobrazeno 1 - 10
of 21
pro vyhledávání: '"JORGE VILLANOVA BIAZUS"'
Autor:
Ana Claudia Souza Palmer, Andressa Souza, Vinicius Souza dos Santos, José Antônio Crespo Cavalheiro, Fernando Schuh, Angela Erguy Zucatto, Jorge Villanova Biazus, Iraci Lucena Da S. Torres, Felipe Fregni, Wolnei Caumo
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Adjuvant chemotherapy for breast cancer (ACBC) has been associated with fatigue, pain, depressive symptoms, and disturbed sleep. And, previous studies in non-cancer patients showed that melatonin could improve the descending pain modulato
Externí odkaz:
https://doaj.org/article/f70b56931a1a4842988b5de279d2a869
Publikováno v:
Mastology.
Introduction: Breast cancer treatment has drastically changed in recent decades due to a better understanding of the biology of this disease as well as an increase in diagnostic and therapeutic approaches. Axillary dissection (AD) persists as the sta
Publikováno v:
Mastology.
Introduction: Breast cancer treatment has drastically changed in recent decades due to a better understanding of the biology of this disease as well as an increase in diagnostic and therapeutic approaches. Objective: We aimed to identify prognostic f
Immediate reconstruction with autologous fat grafting: influence in breast cancerregional recurrence
Autor:
CAMILE CESA STUMPF, JORGE VILLANOVA BIAZUS, FERNANDO SCHUH ÂNGELA ERGUY ZUCATTO, RODRIGO CERICATTO, JOSÉ ANTÔNIO CRESPO CAVALHEIRO, ANDREA PIRES SOUTO DAMIN, MÁRCIA PORTELA MELO
Publikováno v:
Revista do Colégio Brasileiro de Cirurgiões, Vol 44, Iss 2, Pp 179-186
to evaluate local and systemic recurrence of breast cancer in patients submitted to autologous fat grafting in the immediate reconstruction after conservative surgery for breast cancer.this is a historical cohort study comparing 167 patients submitte
Immediate reconstruction with autologous fat grafting: influence in breast cancerregional recurrence
Autor:
CAMILE CESA STUMPF, JORGE VILLANOVA BIAZUS, FERNANDO SCHUH ÂNGELA ERGUY ZUCATTO, RODRIGO CERICATTO, JOSÉ ANTÔNIO CRESPO CAVALHEIRO, ANDREA PIRES SOUTO DAMIN, MÁRCIA PORTELA MELO
Publikováno v:
Revista do Colégio Brasileiro de Cirurgiões, Vol 44, Iss 2, Pp 179-186
ABSTRACT Objective: to evaluate local and systemic recurrence of breast cancer in patients submitted to autologous fat grafting in the immediate reconstruction after conservative surgery for breast cancer. Methods: this is a historical cohort study c
Externí odkaz:
https://doaj.org/article/a04e77a296374c5398b6dfdaa0429459
Autor:
Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eva Sedlackova, Eva Segelov, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, Euan Walpole, David Wyld, Andrew Wardley, Pavel Vitek, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff
Publikováno v:
Breast cancer research and treatment. 131(1)
Letrozole, an aromatase inhibitor, is ineffective in the presence of ovarian estrogen production. Two subpopulations of apparently postmenopausal women might derive reduced benefit from letrozole due to residual or returning ovarian activity: younger
Autor:
Elisabetta Munzone, Zsolt Horváth, Eva Segelov, Jose Luis González Larriba, Jorge Villanova Biazus, David Wyld, Andrew Wardley
Publikováno v:
Breast Cancer Research : BCR
The Breast International Group (BIG) 1-98 study is a four-arm trial comparing 5 years of monotherapy with tamoxifen or with letrozole or with sequences of 2 years of one followed by 3 years of the other for postmenopausal women with endocrine-respons
Autor:
Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Giuseppe Procopio, Eva Sedlackova, Eva Segelov, Tamas Hickish, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, Euan Walpole, Magdolna Dank, David Wyld, Andrew Wardley, Pavel Vitek, Manuela Rabaglio, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff
Summary Background Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7bd5b09eeb5b509962aef78fc5bdfca
https://www.ncbi.nlm.nih.gov/pubmed/22018631
https://www.ncbi.nlm.nih.gov/pubmed/22018631
Autor:
Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eva Segelov, Tamas Hickish, Javier Martin-Broto, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, David Wyld, Andrew Wardley, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Laurence Gladieff
Publikováno v:
The New England journal of medicine. 361(8)
BACKGROUND: The aromatase inhibitor letrozole, as compared with tamoxifen, improves disease-free survival among postmenopausal women with receptor-positive early breast cancer. It is unknown whether sequential treatment with tamoxifen and letrozole i
Autor:
Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eugenio Maiorano, Eva Sedlackova, Eva Segelov, Tamas Hickish, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, Mauro Giuseppe MASTROPASQUA, Wojciech Olszewski, David Wyld, Gaetan MacGrogan, Andrew Wardley, Pavel Vitek, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34)
PurposeTo evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.Patients and MethodsBreast Internationa